Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Mizuho Maintains Buy on Alibaba Group Holding, Lowers Price Target to $180

Mizuho analyst James Lee maintains Alibaba Group Holding (NYSE:BABA) with a Buy and lowers the price target from $215 to $180.

byBenzinga Newsdesk

January 31, 2022

1 minute read

Mizuho analyst James Lee maintains Alibaba Group Holding (NYSE:BABA) with a Buy and lowers the price target from $215 to $180.

Evercore ISI Group Upgrades Macy’s to Outperform, Announces $50 Price Target

By Benzinga Newsdesk

Today, 1:48 PM

Evercore ISI Group analyst Omar Saad upgrades Macy's (NYSE:M) from In-Line to Outperform and announces $50 price target.

Grab Expects Adjusted EBITDA Breakeven By H2 2024

By Anusuya Lahiri

Today, 1:48 PM

During its first Investor Day, Grab Holdings Limited (NASDAQ:GRAB) shared its plans to break even on a Group Adjusted EBITDA basis by…

GRAB

Morgan Stanley Maintains Equal-Weight on Under Armour, Raises Price Target to $10

By Benzinga Newsdesk

Today, 1:48 PM

Morgan Stanley analyst Kimberly Greenberger maintains Under Armour (NYSE:UAA) with a Equal-Weight and raises the price target from $8 to $10.

UAA

NanoVibronix Shares Gain As PainShield Shows Effectiveness In Treating Soft Tissue Pain

By Vandana Singh

Today, 1:48 PM

NanoVibronix Inc (NASDAQ:NAOV) has announced results from a randomized, double-blind study to evaluate the safety and effectiveness of the NanoVibronix PainShield.…

NAOV

Mizuho Maintains Buy on Alibaba Group Holding, Lowers Price Target to $180

Related Posts

Evercore ISI Group Upgrades Macy’s to Outperform, Announces $50 Price Target

Grab Expects Adjusted EBITDA Breakeven By H2 2024

Morgan Stanley Maintains Equal-Weight on Under Armour, Raises Price Target to $10

NanoVibronix Shares Gain As PainShield Shows Effectiveness In Treating Soft Tissue Pain